Valuation: Inotiv, Inc.

Market Cap 387K 339K 314K 289K 544K 37.34M 553K 3.75M 1.47M 18.27M 1.45M 1.42M 62.95M P/E 2024
-0.41x
P/E 2025 -0.69x
Enterprise Value 438M 384M 355M 326M 616M 42.23B 626M 4.24B 1.66B 20.66B 1.64B 1.61B 71.19B EV / Sales 2024
0.95x
EV / Sales 2025 0.95x
Free-Float
91.39%
Yield 2024 *
-
Yield 2025 -
1 day-26.00%
1 week-38.33%
Current month+7.77%
1 month-23.45%
3 months-95.99%
6 months-98.05%
Current year-98.03%
1 week 0.01
Extreme 0.011
0.03
1 month 0.01
Extreme 0.007
0.03
Current year 0.01
Extreme 0.007
0.65
1 year 0.01
Extreme 0.007
2.44
3 years 0.01
Extreme 0.007
11.42
5 years 0.01
Extreme 0.007
60.66
10 years 0.01
Extreme 0.007
60.66
Manager TitleAgeSince
Chief Executive Officer 67 12/01/2019
Director of Finance/CFO 61 06/03/2020
Compliance Officer 49 23/10/2023
Director TitleAgeSince
Chairman 71 26/03/2024
Director/Board Member 60 02/07/2018
Director/Board Member 67 12/01/2019
Date Insider Type Main position Quantity % Market Cap.
18/6/26 Tax

Director

-6,071 0.0174%
18/6/26 Tax

Controller/Auditor

-5,855 0.0168%
18/6/26 Tax

Chief Operating Officer

-5,769 0.0165%
Change 5-day change 1-year change 3-year change Capi.($)
-26.00%-38.33%-99.37%-99.78% 387K
-0.49%-3.58%-0.84%+2.13% 49.18B
-3.10%-0.13%+378.16%+584.97% 39.58B
-0.46%+2.77%+7.01%+61.95% 34.69B
-1.14%-0.97%+29.30%-9.20% 34.42B
-1.82%-1.48%+0.52%+32.02% 27.11B
-3.54%-4.12% - - 16.21B
-1.82%+0.74%+72.92%+116.33% 15.36B
+1.17%+3.10%+15.87%+16.79% 14.05B
-2.25%+0.28%+19.29%-32.68% 13.02B
Average -3.32%-3.99%+46.98%+74.73% 24.36B
Weighted average by Cap. -0.66%-0.38%+78.21%+121.16%

Financials

2024 2025
Net sales 491M 430M 398M 366M 690M 47.32B 701M 4.75B 1.86B 23.15B 1.84B 1.8B 79.77B 513M 450M 416M 382M 721M 49.47B 733M 4.97B 1.95B 24.21B 1.93B 1.88B 83.4B
Net income -108M -95.05M -87.86M -80.81M -152M -10.46B -155M -1.05B -412M -5.12B -407M -398M -17.63B -68.62M -60.15M -55.6M -51.14M -96.48M -6.62B -98.03M -665M -261M -3.24B -258M -252M -11.16B
Net Debt 424M 371M 343M 316M 596M 40.86B 605M 4.1B 1.61B 19.99B 1.59B 1.56B 68.87B 438M 384M 354M 326M 615M 42.19B 625M 4.24B 1.66B 20.64B 1.64B 1.61B 71.13B
Logo Inotiv, Inc.
Inotiv, Inc. is a contract research company engaged in providing nonclinical and analytical drug discovery and development services to the pharmaceutical and medical device industries and selling a range of research-quality animals and diets to the same industries, as well as academia and government clients. Its products and services focus on bringing new drugs and medical devices through the discovery and preclinical phases of development. It operates through two segments: Discovery and Safety Assessment (DSA) and Research Models and Services (RMS). Through DSA segment, it supports the discovery, nonclinical development and clinical development needs of researchers and clinicians for primarily small molecule drug candidates, as well as biotherapeutics and biomedical devices. Through RMS segment, it offers access to a range of small and large research models for basic research and drug discovery and development, as well as specialized models for specific diseases and therapeutic areas.
Employees
1,996
Date Price Change Volume
17/07/26 USD 0.0111 -26.00% 243,786
16/07/26 USD 0.0150 +32.74% 70,600
15/07/26 USD 0.0113 -13.08% 630,714
14/07/26 USD 0.0130 -26.97% 325,742
13/07/26 USD 0.0178 -1.11% 502,086
Trader
-
Investor
-
Global
-
Quality
-
ESG MSCI
BBB

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. NOTVQ Stock